NFE2L2 and neoplasm: Furthermore, overexpression of CUL3 in LUAD patients (resulting in NRF2 degradation) has been related to a reduction of tumor growth in vivo and a better overall survival illustrating the involvement of NRF2 in LUAD progression [118].